Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with exon 11 mutation

Author: Kang Yoon-Koo   Kang Byung   Im Seock-Ah   Lee Jae-Lyun   Park Sook   Kang Won   Chang Heung   Kim Tae   Oh Do-Youn   Jung Kyung   Ryu Min-Hee  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.71, Iss.1, 2013-01, pp. : 43-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content